Zobrazeno 1 - 3 of 3 pro vyhledávání: '"Michael VanAlstine"'
1
Remote patient monitoring using smart phone derived patient reported outcomes and Fitbit data to enable longitudinal predictive modeling in prostate cancer: Feasibility results and lessons on platform development
Autor: Michael VanAlstine, Nipa Sheth, Andrew L. Laccetti, Christopher J. Logothetis, Rebecca S. S. Tidwell
Publikováno v: Journal of Clinical Oncology. 37:e18068-e18068
e18068 Background: Wearable activity trackers and frequent interrogation of remote patient reported outcomes (PROs) have the potential to revolutionize oncology clinical trial design, therapeutic sequencing and patient (pt) safety. Established feasib
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e624e932ce671cf810772deda34a2682
https://doi.org/10.1200/jco.2019.37.15_suppl.e18068
Zobrazit plný text záznamu
3
Real-world experience with cabozantinib in metastatic clear cell renal cell carcinoma (mccRCC)
Autor: Amishi Yogesh Shah, Matthew T. Campbell, Anuradha Chandramohan, Michael VanAlstine, Eric Jonasch, Emily Lemke, Nizar M. Tannir
Publikováno v: Journal of Clinical Oncology. 36:684-684
684 Background: Cabozantinib (C) inhibits tyrosine kinase activity at MET, AXL, and VEGF receptors and is approved in mccRCC after progression on prior VEGFR-TKI. Little off-protocol data exists on tolerability and response. Methods: We retrospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abc1a87b97b1b0ced10a0ecaf465c1a5
https://doi.org/10.1200/jco.2018.36.6_suppl.684
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje